Correspondencia
Lupus cutáneo subagudo inducido por anti-tnf (adalimumab)
Subacute cutaneous lupus induced by anti-tnf (adalimumab)
a Servicio de Medicina Interna, Hospital San Pedro, Logroño, La Rioja, España
b Servicio de Reumatología, Hospital San Pedro, Logroño, La Rioja, España
c Servicio Medicina Familiar y Comunitaria, Hospital San Pedro, Logroño, La Rioja, España
d Servicio de Anatomía Patológica, Hospital San Pedro, Logroño, La Rioja, España
Leído
1826
Vecesse ha leído el artículo
1018
Total PDF
808
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 5 | 0 | 6 | 6 |
| 2025 4 | 0 | 5 | 5 |
| 2025 3 | 0 | 7 | 7 |
| 2025 2 | 0 | 6 | 6 |
| 2025 1 | 0 | 11 | 11 |
| 2024 11 | 0 | 9 | 9 |
| 2024 10 | 1 | 3 | 4 |
| 2024 9 | 0 | 4 | 4 |
| 2024 8 | 0 | 2 | 2 |
| 2024 7 | 0 | 4 | 4 |
| 2024 6 | 0 | 2 | 2 |
| 2024 5 | 0 | 8 | 8 |
| 2024 4 | 0 | 8 | 8 |
| 2024 3 | 0 | 3 | 3 |
| 2024 1 | 0 | 2 | 2 |
| 2023 12 | 0 | 4 | 4 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 0 | 4 | 4 |
| 2023 9 | 0 | 2 | 2 |
| 2023 8 | 0 | 7 | 7 |
| 2023 7 | 0 | 7 | 7 |
| 2023 6 | 0 | 2 | 2 |
| 2023 5 | 0 | 4 | 4 |
| 2023 4 | 0 | 22 | 22 |
| 2023 3 | 8 | 6 | 14 |
| 2023 2 | 0 | 5 | 5 |
| 2022 1 | 0 | 8 | 8 |
| 2022 12 | 0 | 12 | 12 |
| 2022 11 | 0 | 10 | 10 |
| 2022 10 | 0 | 9 | 9 |
| 2022 9 | 0 | 31 | 31 |
| 2022 8 | 0 | 7 | 7 |
| 2022 7 | 0 | 2 | 2 |
| 2022 6 | 0 | 3 | 3 |
| 2022 5 | 0 | 2 | 2 |
| 2022 4 | 0 | 2 | 2 |
| 2022 3 | 0 | 8 | 8 |
| 2022 2 | 0 | 2 | 2 |
| 2021 1 | 0 | 13 | 13 |
| 2021 12 | 0 | 20 | 20 |
| 2021 11 | 0 | 5 | 5 |
| 2021 10 | 0 | 2 | 2 |
| 2021 9 | 0 | 3 | 3 |
| 2021 8 | 0 | 3 | 3 |
| 2021 7 | 0 | 2 | 2 |
| 2021 6 | 0 | 8 | 8 |
| 2021 5 | 0 | 4 | 4 |
| 2021 4 | 0 | 8 | 8 |
| 2021 3 | 0 | 14 | 14 |
| 2021 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 5 | 5 |
| 2020 12 | 0 | 8 | 8 |
| 2020 11 | 0 | 2 | 2 |
| 2020 9 | 0 | 4 | 4 |
| 2020 8 | 0 | 15 | 15 |
| 2020 7 | 0 | 4 | 4 |
| 2020 6 | 0 | 4 | 4 |
| 2020 5 | 0 | 6 | 6 |
| 2020 4 | 0 | 4 | 4 |
| 2020 3 | 0 | 2 | 2 |
| 2020 2 | 0 | 5 | 5 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 0 | 6 | 6 |
| 2019 11 | 0 | 5 | 5 |
| 2019 10 | 0 | 8 | 8 |
| 2019 9 | 0 | 11 | 11 |
| 2019 8 | 0 | 4 | 4 |
| 2019 7 | 0 | 17 | 17 |
| 2019 6 | 0 | 13 | 13 |
| 2019 5 | 0 | 46 | 46 |
| 2019 4 | 0 | 13 | 13 |
| 2019 3 | 0 | 5 | 5 |
| 2019 2 | 0 | 3 | 3 |
| 2019 1 | 0 | 6 | 6 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 0 | 5 | 5 |
| 2018 9 | 0 | 4 | 4 |
| 2018 8 | 0 | 11 | 11 |
| 2018 7 | 0 | 15 | 15 |
| 2018 6 | 0 | 9 | 9 |
| 2018 5 | 0 | 19 | 19 |
| 2018 4 | 0 | 15 | 15 |
| 2018 3 | 0 | 5 | 5 |
| 2018 2 | 60 | 12 | 72 |
| 2018 1 | 65 | 9 | 74 |
| 2017 12 | 61 | 9 | 70 |
| 2017 11 | 48 | 14 | 62 |
| 2017 10 | 48 | 14 | 62 |
| 2017 9 | 23 | 13 | 36 |
| 2017 8 | 29 | 9 | 38 |
| 2017 7 | 19 | 11 | 30 |
| 2017 6 | 37 | 31 | 68 |
| 2017 5 | 26 | 18 | 44 |
| 2017 4 | 18 | 9 | 27 |
| 2017 3 | 22 | 72 | 94 |
| 2017 2 | 96 | 13 | 109 |
| 2016 1 | 21 | 13 | 34 |
| 2016 12 | 42 | 19 | 61 |
| 2016 11 | 53 | 14 | 67 |
| 2016 10 | 33 | 17 | 50 |
| 2016 9 | 37 | 29 | 66 |
| 2016 8 | 33 | 12 | 45 |
| 2016 7 | 14 | 11 | 25 |
| 2016 5 | 0 | 7 | 7 |
| 2016 3 | 0 | 3 | 3 |
| 2016 2 | 0 | 4 | 4 |
| 2015 1 | 0 | 5 | 5 |
| 2015 12 | 1 | 0 | 1 |
| 2015 10 | 2 | 7 | 9 |
| 2015 9 | 2 | 3 | 5 |
| 2015 8 | 2 | 3 | 5 |
| 2015 7 | 0 | 3 | 3 |
| 2015 6 | 0 | 3 | 3 |
| 2015 4 | 0 | 1 | 1 |
| 2015 2 | 0 | 2 | 2 |
| 2015 1 | 0 | 2 | 2 |
| 2014 12 | 0 | 3 | 3 |
| 2014 10 | 0 | 2 | 2 |
| 2014 9 | 1 | 3 | 4 |
| 2014 8 | 1 | 2 | 3 |
| 2014 7 | 2 | 2 | 4 |
| 2014 6 | 1 | 1 | 2 |
| 2014 5 | 1 | 1 | 2 |
| 2014 4 | 1 | 0 | 1 |
Mostrar todo
